Aloe Royal Jelly Powder Contributes to Maintain Normal Immunity: a Randomized Clinical Trial

Abstract

To study the safety and the function of maintaining normal immunity of product with royal jelly lyophilized powder and whole-leaf aloe drying powder as main raw materials. Methods: Selected 125 subjects qualified for inclusion/exclusion criteria for a trial test. (The trial group lost 9 subjects. The control group lost 6 subjects.54 effective subjects of trial group includes 12 men and 42 women. 56 effective subjects of control group including 9 men and 47 women.) The trial group was evaluated by self-control and inter-group comparison, after 90 days of continuous use of aloe royal jelly. Results: There are significant differences in the overall feeling, physiological feeling, psychological feeling and comprehensive evaluation of the individuals in the trial group after 90 days (P<0.001), which are higher than before. The control group has no statistically significant difference in the comprehensive evaluation before and after the trial (P>0.05). The ratio of CD4/CD8, IgG, IgA and IgM in the trial group and the placebo control group are above the normal low-limit. There is no obvious abnormality in indicators of blood test, blood biochemistry, liver and kidney function and other clinical tests. Conclusion: Aloe royal jelly powder contributes to maintain normal immune function and has no harmful effect to the health of subjects.